Literature summary for 3.4.22.15 extracted from

Liu, Y.; Li, X.; Peng, D.; Tan, Z.; Liu, H.; Qing, Y.; Xue, Y.; Shi, G.P.
Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease (2009), Am. J. Cardiol., 103, 476-481.

Search for more literature for 3.4.22.15

Application

Application	Comment	Organism
medicine	serum cathepsin L levels are significantly higher in patients with coronary heart disease than in those without coronary heart disease. Patients with unstable angina pectoris have higher serum cathepsin L levels than those with stable angina pectoris. Of patients with acute coronary syndrome, those with acute myocardial infarction have higher serum cathepsin L levels than those with unstable angina pectoris, and patients with previous myocardial infarction have the highest levels. Serum cathepsin L associates positively with number of coronary branch luminal narrowings, Gensini scores, high-sensitivity C-reactive protein, fasting glucose, and cigarette smokers, but inversely with high-density lipoprotein and apolipoprotein A1	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	patients with coronary heart disease	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
aorta	increased level of cathepsin L in atherosclerotic lesions compared with healthy aortas	Homo sapiens	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)